Anne Lígia Dokkedal, Natalia Moretti Violato, João M. Rezende-Neto, Floriano P. Silva-Junior, Mario Roberto Senger, Luiz Leonardo Saldanha, Aislan Quintiliano Delgado, Henrique J. N. Morgan, José Roberto Bosqueiro, Laís Goyos Pieroni, Nathalia Ap. De Paula Camaforte, Priscilla Maria Ponce Vareda, Universidade Estadual Paulista (Unesp), and Oswaldo Cruz Inst FIOCRUZ
Made available in DSpace on 2019-10-04T12:36:58Z (GMT). No. of bitstreams: 0 Previous issue date: 2019-01-01 Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Context: Bauhinia L. species, including Bauhinia holophylla (Bong.) Steud. (Fabaceae), have traditionally been used to treat diabetes. Bauhinia is a complex botanical genus, and the indiscriminate use of the diverse Bauhinia species is reflected in the experimental divergence of their medicinal potential. Objective: The hypoglycaemic and hypolipidaemic effects, molecular mechanism of action and phytochemical properties of an authentic extract of B. holophylla leaves were evaluated. Materials and methods: A phytochemical study of a 70% EtOH extract was performed using FIA-ESI-IT-MS/MSn and HPLC-PAD-ESI-IT-MS. The extract (200 or 400 mg/kg b.w.) was administered for 14 days to streptozotocin-induced diabetic Swiss mice. Glucose tolerance and insulin sensitivity, blood parameters, gene and protein expression, and the in vivo and in vitro inhibition of intestinal glucosidases were assessed. Results: HPLC-PAD-ESI-IT-MS analysis identified flavonoid derivatives of quercetin, myricetin, luteolin and kaempferol. Treatment with 400 mg/kg of the extract reduced blood glucose (269.0 +/- 32.4 mg/dL vs. 468.0 +/- 32.2 mg/dL for diabetic animals), improved glucose tolerance, decreased cholesterol and triglyceride levels, and increased the mRNA expression of proteins involved in glucogenesis in the liver and muscle, such as PI3-K/Akt, GS, GSK3-beta (ser-9), AMPK and Glut4. The activity of intestinal maltase was inhibited in vitro (IC50: 43.0 mu g/mL for the extract compared to 516.4 mu g/mL for acarbose) and in vivo. Discussion and conclusions: Treatment with B. holophylla was associated with a marked hypoglycaemic effect through the stimulation of glycogenesis and inhibition of gluconeogenesis and intestinal glucose absorption, without increasing basal insulinaemia. Sao Paulo State Univ, Inst Biosci, Botucatu, SP, Brazil Oswaldo Cruz Inst FIOCRUZ, Lab Expt & Computat Biochem Drugs, Rio De Janeiro, Brazil Sao Paulo State Univ, Dept Biol Sci, Bauru, SP, Brazil Sao Paulo State Univ, Dept Phys Educ, Bauru, SP, Brazil Sao Paulo State Univ, Inst Biosci, Botucatu, SP, Brazil Sao Paulo State Univ, Dept Biol Sci, Bauru, SP, Brazil Sao Paulo State Univ, Dept Phys Educ, Bauru, SP, Brazil FAPESP: 2009/52237-9 FAPESP: 2013/10708-0 FAPESP: 2016/18628-4